Romano Brothers & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.32M Sell
70,720
-392
-0.6% -$35K 0.74% 37
2026
Q1
$5.11M Sell
71,112
-500
-0.7% -$38.5K 0.58% 55
2025
Q4
$5.68M Sell
71,612
-2,380
-3% -$188K 0.65% 41
2025
Q3
$5.58M Buy
73,992
+630
+0.9% +$43.2K 0.64% 40
2025
Q2
$5.06M Sell
73,362
-1,900
-3% -$125K 0.63% 46
2025
Q1
$5.1M Sell
75,262
-67
-0.1% -$4.01K 0.66% 45
2024
Q4
$3.38M Sell
75,329
-28,288
-27% -$1.59M 0.43% 68
2024
Q3
$6.52M Buy
103,617
+4,966
+5% +$290K 0.81% 32
2024
Q2
$5.83M Sell
98,651
-8,138
-8% -$509K 0.81% 33
2024
Q1
$8.52M Sell
106,789
-445
-0.4% -$34K 1.17% 15
2023
Q4
$8.47M Sell
107,234
-9,225
-8% -$657K 1.26% 15
2023
Q3
$8.13M Sell
116,459
-1,062
-0.9% -$75.2K 1.27% 14
2023
Q2
$8.12M Sell
117,521
-4,762
-4% -$339K 1.21% 14
2023
Q1
$9.09M Sell
122,283
-5,139
-4% -$431K 1.4% 11
2022
Q4
$11.9M Sell
127,422
-594
-0.5% -$57.3K 1.8% 5
2022
Q3
$12.2M Buy
+128,016
New +$12.7M 1.97% 6

Other funds holding CVS

Romano Brothers & Co's CVS Position: Q2 2026 in Review

Romano Brothers & Co reduced its CVS Health (CVS) stake by 0.55% in Q2 2026, selling an estimated $35K and leaving 70,720 shares worth $7.32M. The position accounts for 0.74% of the portfolio, ranked #37.

Romano Brothers & Co first reported a position in CVS in Q3 2022 and has held it in 16 quarters since. The position peaked at $12.2M in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Romano Brothers & Co held 70,720 shares of CVS Health worth $7.32M as of Q2 2026.
  • Romano Brothers & Co sold 392 CVS Health shares in Q2 2026, an estimated $35K.
  • CVS Health made up 0.74% of Romano Brothers & Co's portfolio in Q2 2026, its #37 holding.
  • Romano Brothers & Co first reported a position in CVS Health in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's CVS Health position peaked at $12.2M in Q3 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.